Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Stimulants for kids with ADHD--how to proceed safely.

Ken Mehta S, Jacobs I.

J Fam Pract. 2014 Feb;63(2):E1-5.

PMID:
24527478
2.

Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder.

Perrin JM, Friedman RA, Knilans TK; Black Box Working Group; Section on Cardiology and Cardiac Surgery.

Pediatrics. 2008 Aug;122(2):451-3. doi: 10.1542/peds.2008-1573. No abstract available.

PMID:
18676566
3.

Cardiovascular safety of medication treatments for attention-deficit/hyperactivity disorder.

Newcorn JH, Donnelly C.

Mt Sinai J Med. 2009 Apr;76(2):198-203. doi: 10.1002/msj.20096. No abstract available.

PMID:
19306385
4.

[Cardiovascular risk assessment for the use of ADHD drugs in children].

Berg A, Bråtane E, Odland HH, Brudvik C, Rosland B, Hirth A.

Tidsskr Nor Laegeforen. 2014 Apr 8;134(7):710-4. doi: 10.4045/tidsskr.13.0565. eCollection 2014 Apr 8. Review. Norwegian.

5.

[Medication for ADHD and the risk of cardiovascular mortality].

Kalverdijk LJ, Buitelaar JK, van der Gaag RJ.

Ned Tijdschr Geneeskd. 2006 Oct 14;150(41):2283-4; author reply 2284. Dutch. No abstract available.

PMID:
17078147
6.

Reexamining the emperor's new clothes: ambiguities in current cardiac screening recommendations for youth with attention deficit hyperactivity disorder.

Leslie LK, Alexander ME, Trikalinos TA, Cohen JT, Parsons SK, Newburger JW.

Circ Cardiovasc Qual Outcomes. 2008 Nov;1(2):134-7. doi: 10.1161/CIRCOUTCOMES.108.825232. No abstract available.

7.

Stimulants and sudden death: what is a physician to do?

Wilens TE, Prince JB, Spencer TJ, Biederman J.

Pediatrics. 2006 Sep;118(3):1215-9. Review.

PMID:
16951018
8.

Central stimulants in the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents. A naturalistic study of the prescription in Sweden, 1977-2007.

Janols LO, Liliemark J, Klintberg K, von Knorring AL.

Nord J Psychiatry. 2009 Nov;63(6):508-16. doi: 10.3109/08039480903154534.

PMID:
19958258
9.

Cardiovascular safety of ADHD medication treatments.

Newcorn JH.

CNS Spectr. 2008 Oct;13(10 Suppl 15):5-8. No abstract available.

PMID:
18955948
10.

Medications for attention deficit hyperactivity disorder: cardiovascular concerns.

Wooltorton E.

CMAJ. 2006 Jul 4;175(1):29. Epub 2006 Jun 13. No abstract available.

11.

Modeled economic evaluation of alternative strategies to reduce sudden cardiac death among children treated for attention deficit/hyperactivity disorder.

Denchev P, Kaltman JR, Schoenbaum M, Vitiello B.

Circulation. 2010 Mar 23;121(11):1329-37. doi: 10.1161/CIRCULATIONAHA.109.901256. Epub 2010 Mar 8.

12.

The rise and fall of ADHD child prescribing in Western Australia: lessons and implications.

Whitely M.

Aust N Z J Psychiatry. 2012 May;46(5):400-3. doi: 10.1177/0004867412444864. No abstract available.

PMID:
22535289
13.

ADHD drugs and cardiovascular risk.

Rappley MD, Moore JW, Dokken D.

N Engl J Med. 2006 May 25;354(21):2296-8; author reply 2296-8. No abstract available.

PMID:
16729375
14.

Cardiac risk assessment before the use of stimulant medications in children and youth: A joint position statement by the Canadian Paediatric Society, the Canadian Cardiovascular Society, and the Canadian Academy of Child and Adolescent Psychiatry.

Warren AE, Hamilton RM, Bélanger SA, Gray C, Gow RM, Sanatani S, Côté JM, Lougheed J, LeBlanc J, Martin S, Miles B, Mitchell C, Gorman DA, Weiss M, Schachar R.

Can J Cardiol. 2009 Nov;25(11):625-30. Review.

15.
16.

ECGs before stimulants in children.

[No authors listed]

Med Lett Drugs Ther. 2008 Jul 28;50(1291):60. No abstract available.

PMID:
18654112
17.

[Medication for ADHD and the risk of cardiovascular mortality].

Langendijk PN, Wilde AA.

Ned Tijdschr Geneeskd. 2006 Aug 5;150(31):1713-4. Dutch.

PMID:
16924941
18.

The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective.

Pottegård A, Bjerregaard BK, Glintborg D, Kortegaard LS, Hallas J, Moreno SI.

Eur J Clin Pharmacol. 2013 Mar;69(3):589-98. doi: 10.1007/s00228-012-1344-0. Epub 2012 Jul 19.

PMID:
22811260
19.

Attention-deficit hyperactivity disorder (ADHD) treatment and sudden death.

Besag FM.

Drug Saf. 2009;32(11):1097-100. doi: 10.2165/11530340-000000000-00000. No abstract available.

PMID:
19810781
20.

Supplemental Content

Support Center